Gynecology
Ovarian or Peritoneal:
Genentech #AVF4095g / WIRB #20070435: OCEANS: A Phase II, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gemcitabine + Bevacizumab in Patients with Platinum Sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma For first recurrence only
Cervical or Endometrial:
ACRIN #6682/IRB #H-28128: Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer (pending)
